J. Greshock

发表

High-resolution analysis of DNA copy number using oligonucleotide microarrays.

M. Shapero, Jing Huang, K. W. Jones, 2004, Genome research.

Subtype and pathway specific responses to anticancer compounds in breast cancer

Joshua M. Stuart, Laura M. Heiser, Nicholas J. Wang, 2011, Proceedings of the National Academy of Sciences.

Integrative Genomic Analysis of Phosphatidylinositol 3′-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer

Joel Greshock, George Coukos, N. Yang, 2007, Clinical Cancer Research.

Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer.

K. Owzar, J. Greshock, B. Inman, 2016, European urology.

A comparison of DNA copy number profiling platforms.

L. Chin, A. Protopopov, I. Perna, 2008, Cancer research.

microRNAs exhibit high frequency genomic alterations in human cancer.

Tara L. Naylor, A. Hatzigeorgiou, N. Yang, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.

Jennifer G. Abelin, Ying S. Ting, Michael S. Rooney, 2019, Immunity.

Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.

Tara L. Naylor, M. Ringnér, M. Stratton, 2005, Cancer research.

1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis.

Shaying Zhao, Adam A. Margolin, Joel Greshock, 2003, Genome research.

Molecular target class is predictive of in vitro response profile.

Joel Greshock, Richard Wooster, J. Greshock, 2010, Cancer research.

Population Frequencies of Single Nucleotide Polymorphisms (SNPs) in Immuno-Modulatory Genes

M. Lux, T. Rebbeck, B. Weber, 2003, Human Heredity.

Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability

Joel Greshock, Nancy Liu-Sullivan, Richard Wooster, 2010, Molecular Cancer Therapeutics.

Good practice guidelines for biomarker discovery from array data: a case study for breast cancer prognosis

Leming Shi, Jie Cheng, Shu Zheng, 2013, BMC Systems Biology.

99 POSTER Models for response to the MEK inhibitor GSK1120212 confirm RAS and BRAF mutations as predictive biomarkers and suggest other, unexpected tumor types for clinical evaluation

B. Weber, J. Greshock, R. Wooster, 2008 .

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

Katie M. Campbell, Christopher A. Miller, Brian J. Stevenson, 2020, Cell.

Combined Phosphatase and Tensin Homolog (PTEN) Loss and Fatty Acid Synthase (FAS) Overexpression Worsens the Prognosis of Chinese Patients with Hepatocellular Carcinoma

Jiuhong Kang, J. Greshock, K. Bachman, 2012, International journal of molecular sciences.

CGH data analysis

Adam A. Margolin, B. Weber, A. Margolin, 2005 .

Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines

Joel Greshock, Richard Wooster, R. Wooster, 2008, Molecular Cancer Therapeutics.

Array based CGH and FISH fail to confirm duplication of 8p22-p23.1 in association with Kabuki syndrome

E. Zackai, B. Weber, J. Greshock, 2005, Journal of Medical Genetics.

Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma.

B. Weber, A. King, J. Maris, 2003, The Lancet. Oncology.

Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era.

B. Weber, J. Maris, J. Greshock, 2005, Cancer letters.

Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases Experimental Therapeutics, Molecular Targets, and Chemical Biology

K. Yamaguchi, J. Greshock, R. Wooster, 2009 .

Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.

Mark Rosenzweig, Joel Greshock, Doron Lipson, 2015, Cancer discovery.

High overexpression of fatty acid synthase is associated with poor survival in Chinese patients with gastric carcinoma

J. Greshock, B. Ye, Xuehua Zhu, 2012, Experimental and therapeutic medicine.

Distinct MHC gene expression patterns during progression of melanoma

Joel Greshock, Xiaolu Yang, Meenhard Herlyn, 2009, Genes, chromosomes & cancer.

Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization.

Joel Greshock, George Coukos, Katherine Nathanson, 2007, Cancer research.

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Ying S. Ting, R. Govindan, Michael S. Rooney, 2020, Cell.

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

B. Weber, Lin Zhang, D. Katsaros, 2008, Cancer biology & therapy.

Transcriptional Regulation of PIK3CA Oncogene by NF-κB in Ovarian Cancer Microenvironment

N. Yang, Lin Zhang, D. Katsaros, 2008, PloS one.

Transcriptional Regulation of PIK 3 CA Oncogene by NF-kappa B in Ovarian Cancer Microenvironment

N. Yang, Lin Zhang, D. Katsaros, 2022 .

High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization

Joel Greshock, Tara L. Naylor, Yan Wang, 2005, Breast Cancer Research.

Ultraconserved Elements in Vertebrate Genomes

Lin Zhang, G. Coukos, J. Greshock, 2009 .

A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer.

Hongzhe Li, Yiling Lu, Joel Greshock, 2014, Cancer cell.

Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome

B. Weber, Lin Zhang, P. Gimotty, 2011, Genes, chromosomes & cancer.

Antitumor activity of an allosteric inhibitor of centromere-associated protein-E

Neysa Nevins, W. D. Cornwell, R. Annan, 2010, Proceedings of the National Academy of Sciences.

Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells

Jennifer B Dennison, G. Mills, J. Briand, 2013, Cancer & Metabolism.

Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436)

K. Nathanson, M. Brown, J. Greshock, 2013, Clinical Cancer Research.

Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells

Jennifer B Dennison, G. Mills, J. Briand, 2013, Cancer & metabolism.

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.

Joel Greshock, Stefano Volinia, George Coukos, 2008, Cancer research.

Ultraconserved elements: Genomics, function and disease

Lin Zhang, G. Coukos, J. Greshock, 2008, RNA biology.

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

Artemis G. Hatzigeorgiou, Victor A. Simossis, Praveen Sethupathy, 2008, Proceedings of the National Academy of Sciences.

Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL.

Joel Greshock, R. Annan, J. Greshock, 2009, Cancer research.

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

Ben H. Park, Frank Diehl, Joel Greshock, 2012, Clinical Cancer Research.

High‐resolution detection and mapping of genomic DNA alterations in neuroblastoma

Adam A. Margolin, Joel Greshock, Cynthia Winter, 2005, Genes, chromosomes & cancer.

Method of primary tumor detection as a risk factor for local and distant recurrence after breast-conservation treatment for early-stage breast cancer.

E. Rosato, B. Weber, D. Fraker, 2008, Clinical breast cancer.

A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer.

Joel Greshock, George Coukos, Xiaowen Hu, 2012, Cancer research.

Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.

K. Yamaguchi, J. Greshock, R. Wooster, 2009, Cancer research.

Systematic analysis of genotype‐specific drug responses in cancer

Yiling Lu, Gordon B Mills, Fan Zhang, 2012, International journal of cancer.

High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells.

Joel Greshock, Levi A Garraway, Fred Harbinski, 2016, Cancer research.

ACombinedArray-BasedComparativeGenomicHybridization and Functional Library Screening Approach Identi fi es mir-30 d As an Oncomir in Cancer

B. Weber, Lin Zhang, Qihong Huang, 2011 .

Loss and reduced expression of PTEN correlate with advanced-stage gastric carcinoma

Jiuhong Kang, J. Greshock, K. Bachman, 2012, Experimental and therapeutic medicine.

Preclinical Development Comprehensive Predictive Biomarker Analysis for MEK Inhibitor GSK 1120212

J. Holbrook, J. Greshock, K. Bachman, 2012 .

Comprehensive Predictive Biomarker Analysis for MEK Inhibitor GSK1120212

J. Holbrook, J. Greshock, K. Bachman, 2011, Molecular Cancer Therapeutics.

Mutation and copy number detection in human cancers using a custom genotyping assay.

J. Greshock, K. Bachman, R. Wooster, 2011, Genomics.

Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma‐derived cell lines

B. Weber, M. Herlyn, K. Nathanson, 2009, Genes, chromosomes & cancer.

STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments.

Christian J Stoeckert, Joel Greshock, Tara L. Naylor, 2006, Genome research.

Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models.

J. Greshock, K. Bachman, B. Ye, 2013, Oncology reports.

PI3K Kinase Inhibitor GSK2126458 (GSK458): Clinical Activity in Select Patient (PT) Populations Defined by Predictive Markers (STUDY P3K112826)

N. Agarwal, J. Schellens, A. Tan, 2012 .

Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction.

Jennifer G. Abelin, Ying S. Ting, Michael S. Rooney, 2021, Immunity.

High Chromosome Number in hematological cancer cell lines is a Negative Predictor of Response to the inhibition of Aurora B and C by GSK1070916

Ramona N Plant, J. Greshock, K. Bachman, 2011, Journal of Translational Medicine.

Characterization of adjacent breast tumors using oligonucleotide microarrays

Michael N Liebman, L. Chodosh, B. Weber, 2001, Breast Cancer Research.

CGHAnalyzer: a stand-alone software package for cancer genome analysis using array-based DNA copy number data

John Quackenbush, John M. Maris, Adam A. Margolin, 2005, Bioinform..

A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer.

M. Goldstein, R. Gaynor, P. Ott, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Abstract CT125: A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broadde novoanti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer

M. Goldstein, R. Govindan, R. Gaynor, 2018, Clinical Trials.

DNA copy number data analysis using the CGHAnalyzer software suite.

Joel Greshock, J. Greshock, 2007, Methods in molecular biology.

Hybridization Histology : Analyses Based on Array Comparative Genomic Cancer Cell Lines as Genetic Models of Their Parent Updated

B. Weber, Lin Zhang, G. Coukos, 2007 .

Effect of Predictive Performance of a Biomarker for the Sample Size of Targeted Designs for Randomized Clinical Trials

Xiwu Lin, J. Greshock, R. Wooster, 2011 .

Abstract 1752: A phase I/IIa, first time in human, open-label dose-escalation study of GSK2636771 in subjects with advanced solid tumors with PTEN deficiency

J. Greshock, M. A. Hardwicke, R. Wooster, 2012 .

Genomic DNA Copy-Number Alterations of the let-7 Family in Human Cancers

Joel Greshock, Xiaowen Hu, Janos L. Tanyi, 2012, PloS one.

A Comparison of DNA Copy Number Profiling Platforms

L. Chin, A. Protopopov, I. Perna, 2007 .